A recent study has suggested that women who take hormone therapy after menopause have an increased risk of breast cancer.
At the same time the study said that women who take hormone therapy and then get breast cancer are at lower risk of dying.
The study was presented at San Antonio Breast Cancer Symposium in Texas.
Study author Sarah F. Marshall, a senior statistician at the University of California-Irvine, told “Hormone therapy seems to give you a particular type of cancerthat is easier to treat.”
Researchers followed 2,800 postmenopausal women who developed breast cancer after starting the study in 1995 and 1996. They tracked those patients until the women’s deaths or through the end of 2005.
Marshall further said, “We found that women who took hormone therapy before their diagnosis were more likely to be diagnosed with estrogen receptor-positive cancer, as well as having breast cancers.”
Related News
- Decrease in hormone therapy use may reduce breast cancer risk
- Risk of breast cancer relapse can linger 5 years after systemic therapy
- Shorter, intense therapy better way to treat breast cancer
- High insulin levels increase breast cancer risk
- Hormone replacement therapy cuts colorectal cancer risk in women
